Call MEDISCA now at 1-800-932-10391300 786 392

MEDISCA News at Your Fingertips

Medisca Signs Deal as Exclusive Global Distributor outside the USA & Israel for the Padagis Line of ORA Products

1/12/2022

MONTREAL, Q.C. (January 12, 2022) – On December 9, 2021, Medisca entered into an exclusive global manufacture, supply, license and distribution agreement with Padagis (formerly, the Rx Division of Perrigo) for their ORA Product Line consisting of the following Padagis products in finished form ORA-Plus®, ORA-Sweet®, ORA-Sweet® SF, ORA-Blend®, and ORA-Blend® SF.

MEDISCA and fellow industry leaders lobby for revisions to compounded expiry dates and succeed

8/13/2021

Over the last several months, MEDISCA Australia along with other industry leaders have been actively putting forward to the Australian Pharmaceutical Formulary & Handbook (APF), scientific rationale for longer expiry dates for compounded preparations. Medisca is now pleased to see the efforts of the compounding community come to fruition.

MEDISCA Sponsors LP3 Network’s Virtual Student Event Drawing Over 350 Pharmacy Students Worldwide

3/29/2021

On March 19, 2021, future pharmacists from over 35 colleges came together to participate in a live FREE Virtual Student Event sponsored by Medisca, a global leader in the compounding pharmaceutical industry. The event, created and hosted by LP3 Network, attracted over 350 students from more than 10 countries and sought to promote the industry through interactive discussions and first-hand narratives about the vital role that compounding pharmacies played during the COVID-19 pandemic.

Medisca Removes Potential Allergens from Topical Products and Provides Essential BUD Testing to Support Clients

2/9/2021

Medisca removes potential allergens from topical products and provides essential BUD testing to support clients.

MEDISCA Announces Exclusive Partnership with ANANDA HEALTH for Global Distribution of Full Spectrum CBD

1/19/2021

MEDISCA, a global leader in the pharmaceutical compounding industry, is proud to announce a partnership with Ananda Health, the leading CBD provider to US independent pharmacies.

MEDISCA retains position as industry leader and innovator for planetary mixers via its patent portfolio

9/22/2020

MEDISCA, a global leader in the personalized pharmaceutical industry, has announced that the revolutionary compounding technology, repurposed and optimized over a seven-year period, is available exclusively from MEDISCA, and, therefore, MEDISCA is actively taking steps to inform its competitors about MEDISCA’s expanding patent portfolio relating to its MAZ mixers.

ARCHIVE


GO BACK


X

We have placed cookies on your device to help make this website better.

We also use cookies to collect information for making reports and to help us improve the site. The cookies collect information in an anonymous form.



Copyright® 1989-2022 Medisca Inc.
All rights reserved